-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FMIdcY1mfsNNK1ikdVHUqWHy0mOfPEGLWikEGFcesqOQ0a9u8CYiF+tXb5//GM5S F7q9iaHSBWa4BX7naUi59Q== 0001179110-09-013313.txt : 20090916 0001179110-09-013313.hdr.sgml : 20090916 20090916190014 ACCESSION NUMBER: 0001179110-09-013313 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090915 FILED AS OF DATE: 20090916 DATE AS OF CHANGE: 20090916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brinkley David L CENTRAL INDEX KEY: 0001302445 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 091073244 MAIL ADDRESS: STREET 1: 901 GATEWAY BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERAVANCE INC CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508086000 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4 1 edgar.xml FORM 4 - X0303 4 2009-09-15 0 0001080014 THERAVANCE INC THRX 0001302445 Brinkley David L THERAVANCE, INC. 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Head of Business Dev. Common Stock 2009-09-15 4 M 0 9000 8.525 A 23207 D Common Stock 2009-09-15 4 S 0 9000 17.8564 D 14207 D Stock Option (Right to Buy) 8.525 2009-09-15 4 M 0 9000 0 D 2010-06-17 Common Stock 9000 67032 D This transaction was executed in multiple trades at prices ranging from $17.82 to $17.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Immediately exercisable. David Brinkley 2009-09-16 -----END PRIVACY-ENHANCED MESSAGE-----